phenylmethyloxadiazole: structure
ID Source | ID |
---|---|
PubMed CID | 98806 |
SCHEMBL ID | 255502 |
MeSH ID | M0044044 |
Synonym |
---|
5-methyl-3-phenyl-[1,2,4]oxadiazole |
1,2,4-oxadiazole, 5-methyl-3-phenyl- |
phenylmethyloxadiazole |
nsc167113 |
1,4-oxadiazole, 5-methyl-3-phenyl- |
nsc-167113 |
1198-98-7 |
SR-01000645228-1 |
5-methyl-3-phenyl-1,2,4-oxadiazole |
A804388 |
nsc 167113 |
4aty54blz9 , |
unii-4aty54blz9 |
CCG-56259 |
AKOS005203176 |
FT-0633470 |
SCHEMBL255502 |
3-phenyl-5-methyl-1,2,4-oxadiazole |
DTXSID60152599 |
5-methyl-3-phenyl-1,2,4-oxadiazole, aldrichcpr |
mfcd00085133 |
AS-62937 |
3-phenyl-5-methyl-1,2,4-oxdiazol |
Z57791725 |
EN300-138471 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |